|
Drug Description
DESCRIPTION
Effexor XR is an extended-release capsule for oral administration that contains venlafaxine hydrochloride, a structurally novel antidepressant. It is designated (R/ S)-1-[ 2-( dimethylamino)-1-(4-methoxyphenyl) ethyl] cyclohexanol hydrochloride or ( )-1-[ -[( dimethylamino) methyl] -p-methoxybenzyl] cyclohexanol hydrochloride and has the empirical formula of C17H27NO2 hydrochloride. Its molecular weight is 313.87. Venlafaxine hydrochloride is a white to off-white crystalline solid with a solubility of 572 mg/ mL in water (adjusted to ionic strength of 0.2 M with sodium chloride). Its octanol: water (0.2 M sodium chloride) partition coefficient is 0.43. Effexor XR is formulated as an extended-release capsule for once-a-day oral administration. Text Continues Below
Drug release is controlled by diffusion through the coating membrane on the spheroids and is not pH dependent. Capsules contain venlafaxine hydrochloride equivalent to 37.5 mg, 75 mg, or 150 mg venlafaxine. Inactive ingredients consist of cellulose, ethylcellulose, gelatin, hypromellose, iron oxide, and titanium dioxide.
|
